IPP Bureau
Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
By IPP Bureau - March 17, 2023
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Mindset Pharma to defend against lawsuit filed by Reunion Neurosciences
By IPP Bureau - March 17, 2023
Mindset disagrees with and denies the allegations set forth from Reunion.
ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
By IPP Bureau - March 17, 2023
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth
By IPP Bureau - March 17, 2023
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
India can lead the “One Earth, One Health” vision, says Minister Mandaviya
By IPP Bureau - March 16, 2023
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
By IPP Bureau - March 16, 2023
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
By IPP Bureau - March 16, 2023
Expands robotics to 20+ specialities
Biocorp and HRA Pharma to jointly develop a medical device innovation
By IPP Bureau - March 16, 2023
Biocorp will receive an initial milestone payment this year
PCI Pharma plans Biologics assembly facility in the Midwest
By IPP Bureau - March 16, 2023
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
By IPP Bureau - March 15, 2023
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
RTsafe announces first use of its PseudoPatient patient-specific quality assurance process
By IPP Bureau - March 15, 2023
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Cepheid launches its first manufacturing unit in India
By IPP Bureau - March 15, 2023
The facility has been set up to manufacture tuberculosis testing cartridges
Philips and Gibraltar Health Authority announce 16-year strategic partnership
By IPP Bureau - March 15, 2023
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
LifeSigns raises Pre-Series A
By IPP Bureau - March 15, 2023
A funding to expand operations and provide better patient care
Pfizer acquires Seagen for US$ 43 billion to battle cancer
By IPP Bureau - March 14, 2023
Proposed combination enhances Pfizer’s position as a leading company in oncology
